Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic

Sergii Kyrychenko1, Eva Poláková, Chifei Kang

  • 1Department of Pharmacology and Physiology, New Jersey Medical School, 185 S. Orange Ave., Newark, NJ 07103, USA.

Cardiovascular Research
|December 25, 2012
PubMed

Insights

Duchenne muscular dystrophy (DMD) cardiac issues stem from increased ryanodine receptor (RyR) calcium sensitivity, driven by oxidative stress and RyR modifications, preceding cardiac dysfunction.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Muscle Physiology

Background:

  • Duchenne muscular dystrophy (DMD) presents significant cardiac complications.
  • Altered calcium (Ca2+) homeostasis and oxidative stress are implicated in DMD cardiac deterioration.
  • The precise cellular mechanisms driving these cardiac changes remain unclear.

Purpose of the Study:

  • Investigate alterations in ryanodine receptor (RyR) Ca2+ release channel activity in DMD.
  • Determine if RyR dysfunction is a cause or consequence of cardiac pathology.
  • Identify post-translational modifications of RyR that contribute to disease progression.

Main Methods:

  • Utilized electrophysiological, imaging, and biochemical techniques.
  • Studied cardiomyocytes from mdx mice, a model for DMD.
  • Assessed Ca2+ responses, excitation-contraction coupling (ECC), sarcoplasmic reticulum Ca2+ load, and leak.

Main Results:

  • Young mdx mice showed hypersensitive ECC and exaggerated Ca2+ responses, normalized by antioxidants and NAD(P)H oxidase/CaMKII inhibitors.
  • Sarcoplasmic reticulum Ca2+ leak increased and load decreased with age in mdx mice.
  • Pharmacological interventions normalized Ca2+ signals and corrected ECC, Ca2+ load, and leak issues.

Conclusions:

  • Increased RyR Ca2+ sensitivity precedes and drives dystrophic cardiomyopathy progression in DMD.
  • Oxidative stress initiates the development of cardiac pathology in DMD.
  • RyR oxidation and subsequent phosphorylation by CaMKII and PKA synergistically worsen cardiac function.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...